• Journal of Ginseng Research
• /
• 제42권1호
• /
• pp.1-8
• /
• 2018

Although ginseng has been shown to have an antiobesity effect, antiobesity-related mechanisms are complex and have not been completely elucidated. In the present study, we evaluated ginseng's effects on food intake, the digestion, and absorption systems, as well as liver, adipose tissue, and skeletal muscle in order to identify the mechanisms involved. A review of previous in vitro and in vivo studies revealed that ginseng and ginsenosides can increase energy expenditure by stimulating the adenosine monophosphate-activated kinase pathway and can reduce energy intake. Moreover, in high fat dietinduced obese and diabetic individuals, ginseng has shown a two-way adjustment effect on adipogenesis. Nevertheless, most of the previous studies into antiobesity effects of ginseng have been animal based, and there is a paucity of evidence supporting the suggestion that ginseng can exert an antiobesity effect in humans.

• Journal of Nutrition and Health
• /
• 제36권5호
• /
• pp.483-490
• /
• 2003

Chitosan, hydroxycitrate and L-carnitine have been known to be antiobesity components. The purpose of this study was to evaluate the combined effects of chitosan, hydroxycitrate and L-carnitine mixture as a potential antiobesity supplement in overweight women. Pre-menopausal healthy females who were overweight (percent ideal body weight > 110) were included in this study. Forty-nine subjects randomly received a placebo (n = 25) or antiobesity-supplement (n = 24), which was a mixture of chitosan, hydroxycitrate, and L-carnitine. Before and after the eight-week experimental period, anthropometric parameters, blood components and computerized tomography were measured. At baseline, the two groups were well matched in terms of age, body mass index and lipid profile. After the eight weeks of potential antiobesity supplementation, the subjects' body fat percent had decreased significantly (p < 0.001) by 5.6% (39.1 $\pm$ 1 vs 36.9 $\pm$ 1%) while lean body mass increased (p < 0.01). Vsceral fat area at the L4 vertebra decreased significantly (p < 0.01) by 8.6% in the supplemented group and the total fat area at the L4 vertebra showed a tendency to decrease (p = 0.051) by 2.4%. Also, in the group given the antiobesity-supplement rather than the placebo, the fasting triglyceride level decreased significantly (p < 0.05) by 10.0%. In addition, serum total cholesterol levels in the antiobesity-supplement group showed a tendency to decrease (p=0.159) by 2.7% (194 $\pm$ 6 vs 189 $\pm$ 6 mg/dl). No side effects were found in either group during the intervention. In conclusion, the present study demonstrated that taking a mixture of chitosan, hydroxycitrate, and L-carnitine as a potential antiobesity supplement for eight weeks produced advantageous changes in the weight and visceral fat accumulation of overweight women without any side effects. (Korean J Nutrition 36(5): 483~490, 2003)

• 한국식품영양과학회지
• /
• 제39권8호
• /
• pp.1126-1131
• /
• 2010

3T3-L1 지방세포에서 상업용 Bacillus subtilis 균주와 순창 민속마을 전통 청국장에서 분리한 Bacillus subtilis KC-3(KCCM 42923) 균주를 이용해 두유를 발효시키고 이를 발효하지 않는 두유와 지방 생성 억제 효과를 비교하였다. 렙틴의 분비량은 B. subtilis MYCO 10001 발효두유(F-MYCO)와 B. subtilis KC-3 발효두유(F-KC)에서 유의적으로 감소하였다. 이러한 지방 생성 억제 효과가 지방의 축적과도 관련이 있는지 알아보기 위하여 지방구를 관찰한 결과 두유와 발효두유 모두에서 축적된 지방의 양이 감소했고 그중 F-KC는 유의적으로 감소하여(p<0.05) 지방의 생성과 축적이 억제된 것을 알 수 있었다. 지방축적의 감소가 지방 분해와도 관련이 있는지 조사하기 위하여 글리세롤의 분비량을 측정하였는데 발효되지 않은 두유의 글리세롤 분비 정도는 control과 비슷하였으나 발효두유의 모든 군에서는 글리세롤의 분비량이 증가하였고 특히 F-KC에서 글리세롤 분비량이 유의적으로 증가하였다. 또한 F-KC의 지방 축적 감소가 지방 생성 억 제로부터 기인된 것인지 조사하기 위하여 지방생성에 중추적 역할을 맡고 있는 전사인자인 $PPAR{\gamma}$와 SREBP-1c의 mRNA 발현을 확인한 결과 두유나 다른 발효두유에 비하여 F-KC에서 이들 유전자 발현이 감소한 것으로 나타났다. 따라서 B. subtilis KC-3에 의해 발효된 두유의 항비만 효과는 지방 생성의 중요한 전사인자인 $PPAR{\gamma}$와 SREBP-1c의 발현 억제에 기인한 것으로서 그 결과 지방의 생성을 억제하고 지방 축적을 효과적으로 감소 시키는 것으로 보인다.

• Journal of Ginseng Research
• /
• 제38권2호
• /
• pp.106-115
• /
• 2014

Background: Gut microbiota is regarded as one of the major factors involved in the control of body weight. The antiobesity effects of ginseng and its main constituents have been demonstrated, but the effects on gut microbiota are still unknown. Methods: To investigate the effect of ginseng on gut microbiota, 10 obese middle-aged Korean women took Panax ginseng extracts for 8 wk and assessment of body composition parameters, metabolic biomarkers, and gut microbiota composition was performed using 16S rRNA gene-based pyrosequencing at baseline and at 8 wk. Significant changes were observed in body weight and body mass index; however, slight changes were observed in gut microbiota. We divided the participants into two groups, the effective and the ineffective weight loss groups, depending on weight loss effect, in order to determine whether the antiobesity effect was influenced by the composition of gut microbiota, and the composition of gut microbiota was compared between the two groups. Results: Prior to ginseng intake, significant differences of gut microbiota were observed between both at phyla and genera and the gut microbiota of the effective and ineffective weight loss groups was segregated on a principal coordinate analysis plot. Conclusion: Results of this study indicate that ginseng exerted a weight loss effect and slight effects on gut microbiota in all participants. In addition, its antiobesity effects differed depending on the composition of gut microbiota prior to ginseng intake.

• 대한의생명과학회지
• /
• 제18권3호
• /
• pp.291-298
• /
• 2012

The antiobesity effect of the mixture of black garlic and Garsinia cambogia extracts (BGG) was investigated by measuring the Oil red O staining and the expressions of adipogenic genes during preadipocyte differentiation by real-time PCR in the 3T3-L1 adipocytes. BGG reduced contents of Oil red O dye in the 3T3-L1 adipocytes. mRNA expression levels of SREBP1c, C/EBPa, aP2/FABP4, and $PPAR{\gamma}$ which are adipogenic transcription factor, in cells treated with BGG were also significantly down regulated. Also, the phosphorylation of AMP-activated protein kinase (AMPK) in L6 cells was more increased by BGG. These results indicate that BGG seems to be more attractive compound for application of industry than individual extracts such as black garlic and Garsinia cambogia, considering it has two effects not only inhibit the preadipocyte differentiation but also activate the phosphorylation of AMPK unlike other two compound.

• 한국생물공학회:학술대회논문집
• /
• 한국생물공학회 2003년도 생물공학의 동향(XII)
• /
• pp.522-523
• /
• 2003

• 생명과학회지
• /
• 제25권3호
• /
• pp.299-306
• /
• 2015

구절초(Chrysanthemum zawadskii)는 국화과에 속하는 다년생 초본으로 일본, 중국 등에 분포하고 있으며 항산 화, 항염증, 항균 등의 생리활성이 알려져 있으나 항비만 활성에 대해서는 보고된 바 없다. 본 연구에서는 구절초 메탄올 추출물(CZME)의 항비만 활성을 췌장 lipase 효소 활성 억제능과 지방세포분화 및 지방 생성에 미치는 영향을 분석하였다. 그 결과 CZME는 농도 의존적으로 lipase 효소 활성을 억제시켰으며, insulin, dexamethasone, 3-isobutyl-1-methylxanthine (MDI)로 분화를 유도한 3T3-L1 preadipocyte를 이용하여 지방세포 분화 및 지방생성에 미치는 영향을 분석한 결과 지방세포 분화, 세포 내 지방 축적, TG 함량 등을 독성 없이 농도의존적으로 억제 하였다. 이러한 구절초의 지방세포 분화 억제능은 핵심 작용 인자인 C/EBPα, C/EBPβ, 그리고 PPARγ의 유전자 및 단백질 발현조절에서 기인함을 확인하였다. 뿐만 아니라 MDI로 분화를 유도한 3T3-L1 preadipocyte에서 생성된 지방의 분해능을 분석한 결과 지방세포 분화 억제뿐만 아니라 지방세포 내 중성지방 또한 유의적으로 분해시키는 것으로 나타났다. 이러한 결과는 구절초가 보유한 췌장 lipase 활성 저해능, 지방세포 분화 억제능, 지방세포내 지방 분해능을 통한 항비만 활성을 처음으로 밝혀낸 것이며 추후 계속적인 연구를 통해 활성 물질의 규명이 필요할 것으로 판단된다.

• Preventive Nutrition and Food Science
• /
• 제13권2호
• /
• pp.66-70
• /
• 2008

In order to develop a functionally improved kochujang with antiobesity effects, garlic-added kochujang was prepared with freeze-dried garlic powder and followed by fermentation for 60 days at $30^{\circ}C$. Antiobesity effect of the garlic-added kochujang was investigated by measuring the leptin secretions and mRNA expression levels of obesity-related gene such as TNF${\alpha}$, PPAR${\gamma}$, C/EBP${\alpha}$, and SREBP1c, in cultured 3T3-L1 adipocytes. Fermentation of garlic-added kochujang led to decreased levels of leptin secretions and reduced the mRNA expression levels of TNF${\alpha}$, PPAR${\gamma}$, C/EBP${\alpha}$, and SREBP1c in the 3T3-L1 adipocytes. Accordingly, these results suggest that the addition of garlic to kochujang has a potential as a valuable functional food for controlling obesity.

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제10권3호
• /
• pp.242-247
• /
• 2005

Caseinomacropeptide (CMP) is a glycopeptide of 64 amino acid residues derived from the C-terminal of mammalian milk K-casein. Recently, human CMP (hCMP) was produced from the recombinant yeast Saccharomyces cerevisiae. In this study, the antiobesity activity of the recombinant hCMP (rhCMP) was investigated in vivo using Sprague-Dawley rats. The rhCMP did not affect the rats fed with a normal fat diet (fat content, $5.0\%$), but decreased the body weight gain of the rats fed with a high fat diet (fat content, $20\%$) by up to $19\%$. Autopsies revealed that the weights of the liver, kidney and adipose tissues decreased when the rats were given the rhCMP, which also reduced the lipid concentrations in the plasma and liver, but enhanced the fecal excretion of lipids. These results suggest that rhCMP prevent the accumulation of lipid by stimulating its fecal excretion, so could be used as a food supplement to alleviate the obesity problem caused by a high fat diet.

• Nutrition Research and Practice
• /
• 제9권6호
• /
• pp.606-612
• /
• 2015

BACKGROUND/OBJECTIVES: Several medicinal properties of Smilax china L. have been studied including antioxidant, anti-inflammatory, and anti-cancer effects. However, the antiobesity activity and mechanism by which the water-soluble fraction of this plant mediates its effects are not clear. In the present study, we investigated the lipolytic actions of the water-soluble fraction of Smilax china L. leaf ethanol extract (wsSCLE) in 3T3-L1 adipocytes. MATERIALS/METHODS: The wsSCLE was identified by measuring the total polyphenol and flavonoid content. The wsSCLE was evaluated for its effects on cell viability, lipid accumulation, glycerol, and cyclic adenosine monophosphate (cAMP) contents. In addition, western blot analysis was used to evaluate the effects on protein kinase A (PKA), PKA substrates (PKAs), and hormone-sensitive lipase (HSL). For the lipid accumulation assay, 3T3-L1 adipocytes were treated with different doses of wsSCLE for 9 days starting 2 days post-confluence. In other cell experiments, mature 3T3-L1 adipocytes were treated for 24 h with wsSCLE. RESULTS: Results showed that treatment with wsSCLE at 0.05, 0.1, and 0.25 mg/mL had no effect on cell morphology and viability. Without evidence of toxicity, wsSCLE treatment decreased lipid accumulation compared with the untreated adipocyte controls as shown by the lower absorbance of Oil Red O stain. The wsSCLE significantly induced glycerol release and cAMP production in mature 3T3-L1 cells. Furthermore, protein levels of phosphorylated PKA, PKAs, and HSL significantly increased following wsSCLE treatment. CONCLUSION: These results demonstrate that the potential antiobesity activity of wsSCLE is at least in part due to the stimulation of cAMP-PKA-HSL signaling. In addition, the wsSCLE-stimulated lipolysis induced by the signaling is mediated via activation of the ${\beta}$-adrenergic receptor.